Literature DB >> 12875108

HIV sequence databases.

Carla Kuiken1, Bette Korber, Robert W Shafer.   

Abstract

Two important databases are often used in HIV genetic research, the HIV Sequence Database in Los Alamos, which collects all sequences and focuses on annotation and data analysis, and the HIV RT/Protease Sequence Database in Stanford, which collects sequences associated with the development of viral resistance against anti-retroviral drugs and focuses on analysis of those sequences. The types of data and services these two databases offer, the tools they provide, and the way they are set up and operated are described in detail.

Mesh:

Substances:

Year:  2003        PMID: 12875108      PMCID: PMC2613779     

Source DB:  PubMed          Journal:  AIDS Rev        ISSN: 1139-6121            Impact factor:   2.500


  31 in total

Review 1.  Origins and evolution of AIDS viruses.

Authors:  P M Sharp; E Bailes; D L Robertson; F Gao; B H Hahn
Journal:  Biol Bull       Date:  1999-06       Impact factor: 1.818

2.  Potent suppression of HIV-1 replication in humans by T-20, a peptide inhibitor of gp41-mediated virus entry.

Authors:  J M Kilby; S Hopkins; T M Venetta; B DiMassimo; G A Cloud; J Y Lee; L Alldredge; E Hunter; D Lambert; D Bolognesi; T Matthews; M R Johnson; M A Nowak; G M Shaw; M S Saag
Journal:  Nat Med       Date:  1998-11       Impact factor: 53.440

3.  Models of amino acid substitution and applications to mitochondrial protein evolution.

Authors:  Z Yang; R Nielsen; M Hasegawa
Journal:  Mol Biol Evol       Date:  1998-12       Impact factor: 16.240

4.  Fourth annual survey of worldwide HIV, SIV, and SHIV challenge studies in vaccinated nonhuman primates.

Authors:  J T Warren; M A Levinson
Journal:  J Med Primatol       Date:  1995-05       Impact factor: 0.667

5.  Tracking changes in HIV-1 envelope quasispecies using DNA heteroduplex analysis.

Authors:  E L Delwart; C J Gordon
Journal:  Methods       Date:  1997-08       Impact factor: 3.608

Review 6.  AIDS as a zoonosis: scientific and public health implications.

Authors:  B H Hahn; G M Shaw; K M De Cock; P M Sharp
Journal:  Science       Date:  2000-01-28       Impact factor: 47.728

7.  Full-length sequence and mosaic structure of a human immunodeficiency virus type 1 isolate from Thailand.

Authors:  J K Carr; M O Salminen; C Koch; D Gotte; A W Artenstein; P A Hegerich; D St Louis; D S Burke; F E McCutchan
Journal:  J Virol       Date:  1996-09       Impact factor: 5.103

8.  Antiretroviral-drug resistance among patients recently infected with HIV.

Authors:  Susan J Little; Sarah Holte; Jean-Pierre Routy; Eric S Daar; Marty Markowitz; Ann C Collier; Richard A Koup; John W Mellors; Elizabeth Connick; Brian Conway; Michael Kilby; Lei Wang; Jeannette M Whitcomb; Nicholas S Hellmann; Douglas D Richman
Journal:  N Engl J Med       Date:  2002-08-08       Impact factor: 91.245

9.  Human immunodeficiency virus type 2 (HIV-2) seroprevalence and characterization of a distinct HIV-2 genetic subtype from the natural range of simian immunodeficiency virus-infected sooty mangabeys.

Authors:  Z Chen; A Luckay; D L Sodora; P Telfer; P Reed; A Gettie; J M Kanu; R F Sadek; J Yee; D D Ho; L Zhang; P A Marx
Journal:  J Virol       Date:  1997-05       Impact factor: 5.103

10.  The heterosexual human immunodeficiency virus type 1 epidemic in Thailand is caused by an intersubtype (A/E) recombinant of African origin.

Authors:  F Gao; D L Robertson; S G Morrison; H Hui; S Craig; J Decker; P N Fultz; M Girard; G M Shaw; B H Hahn; P M Sharp
Journal:  J Virol       Date:  1996-10       Impact factor: 5.103

View more
  81 in total

1.  Chronology and evolution of the HIV-1 subtype C epidemic in Ethiopia.

Authors:  Damien C Tully; Charles Wood
Journal:  AIDS       Date:  2010-06-19       Impact factor: 4.177

2.  Recommendations for the design and use of standard virus panels to assess neutralizing antibody responses elicited by candidate human immunodeficiency virus type 1 vaccines.

Authors:  John R Mascola; Patricia D'Souza; Peter Gilbert; Beatrice H Hahn; Nancy L Haigwood; Lynn Morris; Christos J Petropoulos; Victoria R Polonis; Marcella Sarzotti; David C Montefiori
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

3.  Infectivity and neutralization of simian immunodeficiency virus with FLAG epitope insertion in gp120 variable loops.

Authors:  Melissa E Laird; Ronald C Desrosiers
Journal:  J Virol       Date:  2007-08-08       Impact factor: 5.103

4.  Phylogenetic analysis of population-based and deep sequencing data to identify coevolving sites in the nef gene of HIV-1.

Authors:  Art F Y Poon; Luke C Swenson; Winnie W Y Dong; Wenjie Deng; Sergei L Kosakovsky Pond; Zabrina L Brumme; James I Mullins; Douglas D Richman; P Richard Harrigan; Simon D W Frost
Journal:  Mol Biol Evol       Date:  2009-12-02       Impact factor: 16.240

5.  Genetic and neutralization sensitivity of diverse HIV-1 env clones from chronically infected patients in China.

Authors:  Hong Shang; Xiaoxu Han; Xuanling Shi; Teng Zuo; Mark Goldin; Dan Chen; Bing Han; Wei Sun; Hao Wu; Xinquan Wang; Linqi Zhang
Journal:  J Biol Chem       Date:  2011-02-16       Impact factor: 5.157

6.  Human immunodeficiency virus type 1 subtype B ancestral envelope protein is functional and elicits neutralizing antibodies in rabbits similar to those elicited by a circulating subtype B envelope.

Authors:  N A Doria-Rose; G H Learn; A G Rodrigo; D C Nickle; F Li; M Mahalanabis; M T Hensel; S McLaughlin; P F Edmonson; D Montefiori; S W Barnett; N L Haigwood; J I Mullins
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

7.  Prevalence of drug-resistant HIV-1 in rural areas of Hubei province in the People's Republic of China.

Authors:  Minqi Luo; Huan Liu; Ke Zhuang; Li Liu; Bo Su; Rongrong Yang; Po Tien; Linqi Zhang; Xien Gui; Zhiwei Chen
Journal:  J Acquir Immune Defic Syndr       Date:  2009-01-01       Impact factor: 3.731

8.  Co-lethality studied as an asset against viral drug escape: the HIV protease case.

Authors:  Sophie Brouillet; Thomas Valere; Emmanuelle Ollivier; Laurent Marsan; Anne Vanet
Journal:  Biol Direct       Date:  2010-06-17       Impact factor: 4.540

9.  96 shRNAs designed for maximal coverage of HIV-1 variants.

Authors:  Glen John McIntyre; Jennifer Lynne Groneman; Yi-Hsin Yu; Angel Jaramillo; Sylvie Shen; Tanya Lynn Applegate
Journal:  Retrovirology       Date:  2009-06-04       Impact factor: 4.602

10.  Human immunodeficiency virus type 1, human protein interaction database at NCBI.

Authors:  William Fu; Brigitte E Sanders-Beer; Kenneth S Katz; Donna R Maglott; Kim D Pruitt; Roger G Ptak
Journal:  Nucleic Acids Res       Date:  2008-10-15       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.